In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In silico identification of public neo-antigens in head and neck Cancer for T cell receptor Engineering: Targeting PI3KCA and TP53 missense mutations

Published:2024-09 Issue: Volume:156 Page:106947
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Zenga Joseph,Himburg Heather A.,Wong Stuart J,Kearl Tyce,Hematti Peiman,Jin Victor X.,Memon Abdullah A.,Mathison Angela J.,Awan Musaddiq J.

Funder

National Cancer Institute

Advancing a Healthier Wisconsin Endowment

Publisher

Elsevier BV

Reference10 articles.

1. Pembrolizumab alone or with chemotherapy versus cetuximab with chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck (KEYNOTE-048): a randomised, open-label, phase 3 study;Burtness;Lancet,2019

2. Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer;Redman;J Clin Invest,2022

3. Adoptive cellular therapy in solid tumor malignancies: review of the literature and challenges ahead;Kirtane;J Immunother Cancer,2021

4. Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial;Creelan;Nat Med,2021

5. Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer;Zacharakis;Nat Med,2018

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP